CCT-367766

CAS No. 2229856-58-8

CCT-367766( CCT367766 | CCT 367766 )

Catalog No. M13570 CAS No. 2229856-58-8

CCT-367766 (CCT367766) is a novel heterobifunctional PROTAC that binds and degrades the putative transcription factor regulator Pirin in cells.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 686 In Stock
10MG 938 In Stock
25MG 1444 In Stock
50MG 1841 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    CCT-367766
  • Note
    Research use only, not for human use.
  • Brief Description
    CCT-367766 (CCT367766) is a novel heterobifunctional PROTAC that binds and degrades the putative transcription factor regulator Pirin in cells.
  • Description
    CCT-367766 (CCT367766) is a novel heterobifunctional PROTAC that binds and degrades the putative transcription factor regulator Pirin in cells.
  • In Vitro
    CCT367766 (50-1500 nM; 24 hours) demonstates the depletion of pirin protein as a?the time-dependent hook-effect in SK-OV-3 human ovarian cancer cells.CCT367766 (0.5-50 nM; 2 hours) demonstrates the concentration-dependent depletion of pirin protein after 2 h exposure in SK-OV-3 cells.CCT367766 (0.5-50 nM; 2 hours) dose-dependently rescuses pirin expression from pretreatment of chlorobisamide in SK-OV-3 cells.Western Blot AnalysisCell Line:SK-OV-3 human ovarian cancer cells Concentration:50, 150, 250, 500 and 1500 nMIncubation Time:2 hours, 4 hours, 24 hours Result:Decreased pirin protein expression.Western Blot Analysis Cell Line:SK-OV-3 human ovarian cancer cells Concentration:0.5, 1, 2.5, 5, 7.5, 10, 25, and 50 nM Incubation Time:2 hours Result:Completely degraded pirin just at50 nM treatment.
  • In Vivo
    ——
  • Synonyms
    CCT367766 | CCT 367766
  • Pathway
    PROTACs
  • Target
    PROTAC
  • Recptor
    PROTAC
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2229856-58-8
  • Formula Weight
    946.41
  • Molecular Formula
    C49H48ClN7O11
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C(C1=CC=C2N=C(CN3CCN(CCOCCOCCOC4=CC=CC(C(N5C(CC6)C(NC6=O)=O)=O)=C4C5=O)CC3)C=CC2=C1)NC7=CC(NC(C8=CC=C9OCCOC9=C8)=O)=CC=C7Cl
  • Chemical Name
    N-(2-Chloro-5-(2,3-dihydrobenzo[b][1,4]dioxine-6-carboxamido)phenyl)-2-((4-(2-(2-(2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)ethoxy)ethoxy)ethyl)piperazin-1-yl)methyl)quinoline-6-carboxamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Chessum NEA, et al. J Med Chem. 2017 Dec 14. doi: 10.1021/acs.jmedchem.7b01406.
molnova catalog
related products
  • TL13-12

    TL13-12 is a novel Anaplastic Lymphoma Kinase (ALK)-PROTAC developed through conjugation of TAE684 and the cereblon ligand pomalidomide.

  • Hydroxy-PEG5-Boc

    Hydroxy-PEG6-Boc is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

  • Gefitinib-based PROT...

    Gefitinib-based PROTAC 3 is a VHL-recruiting PROTAC that induces the degradation of EGFR and EGFR mutants with DC50 of 11.7 nM and 22.3 nM for HCC827 cell (Exon 19 del) and H3255 cell (L858R).